Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM

BACKGROUND: Clinical studies have shown that the efficacy of programmed cell death receptor-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors on glioblastoma (GBM) is much lower than what is expected because of the low immunogenicity of GBM. Ferroptosis of cancer cells can induce the maturati...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bao, Ji, Qifeng, Cheng, Ying, Liu, Miao, Zhang, Bangle, Mei, Qibing, Liu, Daozhou, Zhou, Siyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962245/
https://www.ncbi.nlm.nih.gov/pubmed/35351131
http://dx.doi.org/10.1186/s12951-022-01360-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962245/
https://www.ncbi.nlm.nih.gov/pubmed/35351131
http://dx.doi.org/10.1186/s12951-022-01360-6

Ejemplares similares